Tumor Targeted Cuprous‐Based Nanocomposite as Responsive Cascade Nanocatalyst for Efficient Tumor Synergistic Therapy
Chemistry – A European Journal · 2024
DOI: 10.1002/chem.202302961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Weihua Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan, 453007, China. Hauptthemen laut MEDLINE: Neoplasms, Nanocomposites. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Science and Technology Innovation Talents in Universities of Henan Province.
Abstract (Originalsprache)
The single‐functionality of traditional chemodynamic therapy (CDT) reagents usually limits the therapeutic efficacy of cancer treatment. Synergistic nanocomposites that involve cascade reaction provide a promising strategy to achieve satisfactory anticancer effects. Herein, a cuprous‐based nanocomposite (CCS@GOx@HA) is fabricated, which owns the tumor targeting ability and can undergo tumor microenvironment responsive cascade reaction to enhance the tumor therapeutic efficiency significantly. Surface modification of nanocomposite with hyaluronic acid enables the targeted delivery of the nanocomposite to cancer cells. Acid‐triggered decomposition of nanocomposite in cancer cell results in the release of Cu + , Se 2− and GOx. The Cu + improves the Fenton‐like reaction with endogenous H 2 O 2 to generate highly toxic • OH for CDT. While GOx can not only catalyze the in situ generation of endogenous H 2 O 2 , but also accelerate the consumption of intratumoral glucose to reduce nutrient supply in tumor site. In addition, Se 2− further improves the therapeutic effects of CDT by upregulating the reactive oxygen species (ROS) in tumor cells. Meanwhile, the surface modification endows the nanocomposite the good water dispersibility and biocompatibility. Moreover, in vitro and in vivo experiments demonstrate satisfactory anti‐cancer therapeutic performance by the synergistic cascade function of CCS@GOx@HA than CDT alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan, 453007, China.
- Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Henan Normal University, Xinxiang, Henan, 453007, China.
- Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Henan Normal University, Xinxiang, Henan, 453007, China.
ORCID-Profile: Yi Chang, Xiaoming Ma, Yuming Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- Science and Technology Innovation Talents in Universities of Henan Province
- Overseas Expertise Introduction Project for Discipline Innovation
Zitieren
APA
Gao, W., Zhang, J., Ding, L., Chang, Y., Gao, F., Yang, P., Ma, X., & Guo, Y. (2024). Tumor Targeted Cuprous‐Based Nanocomposite as Responsive Cascade Nanocatalyst for Efficient Tumor Synergistic Therapy. Chemistry – A European Journal. https://doi.org/10.1002/chem.202302961
Vancouver
Gao W, Zhang J, Ding L, Chang Y, Gao F, Yang P, et al. Tumor Targeted Cuprous‐Based Nanocomposite as Responsive Cascade Nanocatalyst for Efficient Tumor Synergistic Therapy. Chemistry – A European Journal. 2024. doi:10.1002/chem.202302961
BibTeX
@article{Gao2024,
author = {Gao, Weihua and Zhang, Jie and Ding, Lina and Chang, Yi and Gao, Fangli and Yang, Pengfei and Ma, Xiaoming and Guo, Yuming},
title = {Tumor Targeted Cuprous‐Based Nanocomposite as Responsive Cascade Nanocatalyst for Efficient Tumor Synergistic Therapy},
journal = {Chemistry – A European Journal},
year = {2024},
doi = {10.1002/chem.202302961}
}
EUVIMED